More than 10% of fecal immunochemical test (FIT)–based colorectal cancer screening could not be processed due to unsatisfactory samples. Colorectal cancer (CRC) screening using the fecal ...

Colorectal cancer continues to be one of the leading causes of cancer-related deaths worldwide. However, recent advancements in medical screening have brought new hope in the fight against this deadly ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Pharmacy-based CRC screening programs using FIT can improve early detection, especially in underserved communities, with effective follow-up care. Patients prefer digital updates for negative results ...

A mailed fecal immunochemical test (FIT) outreach followed by patient navigation for those with a positive test increased colorectal cancer (CRC) screening participation at 6 months compared with ...

A new analysis provided “strong” support for starting fecal immunochemical test (FIT) screening at ages 40-49 rather than at the currently recommended age of 50. An exploratory initiative that offered ...

Please provide your email address to receive an email when new articles are posted on . The number needed to screen to detect at least one advanced adenoma was higher among those with no detectable ...

More cases of colorectal cancer are detected at an early stage with screening. This is according to new research based on data from over 278,000 60-year-olds, who were randomly selected to undergo one ...

An at-home FIT test (Fecal Immunochemical Test) is one of the easiest ways to screen for colon cancer. This short explainer video shows who needs a FIT test, how it works, and how to ask your doctor ...

Please provide your email address to receive an email when new articles are posted on . Patients who received mailed outreach had a higher rate of screening completion at 6 months vs. those who ...

Completing one or more fecal immunochemical test (FIT) screenings was associated with a lower risk of death from colorectal cancer, particularly in the left colon, according to a nested case-control ...